Qube Research & Technologies (QRT)
EXAS

Qube Research & Technologies (QRT)’s Exact Sciences EXAS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,500
Closed -$587K – 4068
2024
Q1 		$587K Buy
+8,500
New +$538K ﹤0.01% 2451

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Qube Research & Technologies (QRT)'s EXAS Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,016,238 shares — an estimated $205M sold.

Qube Research & Technologies (QRT) first reported a position in EXAS in Q4 2020 and held it in 9 quarters. The position peaked at $205M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 2,016,238 Exact Sciences shares in Q1 2026, an estimated $205M.
  • Qube Research & Technologies (QRT) first reported a position in Exact Sciences in Q4 2020 and held it in 9 quarters.
  • Qube Research & Technologies (QRT)'s Exact Sciences position peaked at $205M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.